[1]
|
McCrae, K. (2011) Immune Thrombocytopenia: No Longer “Idiopathic”. Cleveland Clinic Journal of Medicine, 78, 358-373. https://doi.org/10.3949/ccjm.78gr.10005
|
[2]
|
Cines, D.B. and McMillan, R. (2007) Pathogenesis of Chronic Immune Thrombocytopenic Purpura. Current Opinion in Hematology, 14, 511-514. https://doi.org/10.1097/MOH.0b013e3282ba5552
|
[3]
|
Bergmann, A.K., Grace, R.F. and Neufeld, E.J. (2010) Ge-netic Studies in Pediatric ITP: Outlook, Feasibility, and Requirements. Annals of Hematology, 89, S95-S103. https://doi.org/10.1007/s00277-009-0865-9
|
[4]
|
Breunis, W.B., van Mirre, E., Bruin, M., et al. (2008) Copy Number Variation of the Activating FCGR2C Gene Predisposes to Idiopathic Thrombocytopenic Purpura. Blood, 111, 1029-1038.
https://doi.org/10.1182/blood-2007-03-079913
|
[5]
|
梅恒, 胡豫. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)解读[J]. 临床内科杂志, 2021, 38(6): 431-432. https://doi.org/10.3969/j.issn.1001-9057.2021.06.023
|
[6]
|
Witkowski, M., Witkowska, M. and Robak, T. (2019) Autoimmune Thrombocytopenia: Current Treatment Options in Adults with a Focus on Novel Drugs. European Journal of Haematology, 103, 531-541.
https://doi.org/10.1111/ejh.13319
|
[7]
|
Erdő-Bonyár, S., Rapp, J., Minier, T., et al. (2019) Toll-Like Receptor Me-diated Activation of Natural Autoantibody Producing B Cell Subpopulations in an Autoimmune Disease Model. Interna-tional Journal of Molecular Sciences, 20, 6152. https://doi.org/10.3390/ijms20246152
|
[8]
|
Niiro, H. and Clark, E.A. (2002) Regulation of B-Cell Fate by Antigen-Receptor Signals. Nature Reviews Immunology, 2, 945-956. https://doi.org/10.1038/nri955
|
[9]
|
Campbell, R., Chong, G. and Hawkes, E.A. (2018) Novel Indications for Bru-ton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies. Journal of Clinical Medicine, 7, 62. https://doi.org/10.3390/jcm7040062
|
[10]
|
Wang, S., Guan, Y., Wang, Y., et al. (2018) Reduced PTEN Involved in Primary Immune Thrombocytopenia via Contributing to B Cell Hyper-Responsiveness. Molecular Immunology, 93, 144-151.
https://doi.org/10.1016/j.molimm.2017.11.010
|
[11]
|
Hofmann, K., Clauder, A.K. and Manz, R.A. (2018) Targeting B Cells and Plasma Cells in Autoimmune Diseases. Frontiers in Immunology, 9, 835. https://doi.org/10.3389/fimmu.2018.00835
|
[12]
|
Robak, E. and Robak, T. (2022) Bruton’s Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives. Journal of Clinical Medicine, 11, 2807. https://doi.org/10.3390/jcm11102807
|
[13]
|
Kuter, D.J., Efraim, M., Mayer, J., et al. (2022) Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. The New England Journal of Medicine, 386, 1421-1431. https://doi.org/10.1056/NEJMoa2110297
|
[14]
|
McGuire, V.A. and Arthur, J.S. (2015) Subverting Toll-Like Re-ceptor Signaling by Bacterial Pathogens. Frontiers in Immunology, 6, 607. https://doi.org/10.3389/fimmu.2015.00607
|
[15]
|
Medzhitov, R. (2001) Toll-Like Receptors and Innate Immunity. Nature Reviews Immunology, 1, 135-145.
https://doi.org/10.1038/35100529
|
[16]
|
Xu, D., Liu, H., Komai-Koma, M. (2004) Direct and Indirect Role of Toll-Like Receptors in T Cell Mediated Immunity. Cell Molecular Immunology, 1, 239-246.
|
[17]
|
Kawai, T. and Akira, S. (2007) TLR Signaling. Seminars in Immunology, 19, 24-32.
https://doi.org/10.1016/j.smim.2006.12.004
|
[18]
|
Honda, K., Taniguchi, T. (2006) IRFs: Master Regulators of Sig-nalling by Toll-Like Receptors and Cytosolic Pattern-Recognition Receptors. Nature Reviews Immunology, 6, 644-658. https://doi.org/10.1038/nri1900
|
[19]
|
Aslam, R., Speck, E.R., Kim, M., et al. (2006) Platelet Toll-Like Receptor Ex-pression Modulates Lipopolysaccharide-Induced Thrombocytopenia and Tumor Necrosis Factor-Alpha Production in Vivo. Blood, 107, 637-641.
https://doi.org/10.1182/blood-2005-06-2202
|
[20]
|
Matzinger, P. (2002) The Danger Model: A Renewed Sense of Self. Science, 296, 301-305.
https://doi.org/10.1126/science.1071059
|
[21]
|
Semple, J.W., Aslam, R., Kim, M., Speck, E.R. and Freedman, J. (2007) Platelet-Bound Lipopolysaccharide Enhances Fc Receptor-Mediated Phagocytosis of IgG-Opsonized Platelets. Blood, 109, 4803-4805.
https://doi.org/10.1182/blood-2006-12-062695
|
[22]
|
Yang, J., Wise, L. and Fukuchi, K.I. (2020) TLR4 Cross-Talk with NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer’s Disease. Frontiers in Immunology, 11, 724. https://doi.org/10.3389/fimmu.2020.00724
|
[23]
|
Gaudino, S.J. and Kumar, P. (2019) Cross-Talk between An-tigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis. Frontiers in Immunology, 10, 360.
https://doi.org/10.3389/fimmu.2019.00360
|
[24]
|
Hirsch, I., Janovec, V., Stranska, R. and Bendriss-Vermare, N. (2017) Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Re-ceptor Pathways in Macrophages and Dendritic Cells. Frontiers in Immunology, 8, 394. https://doi.org/10.3389/fimmu.2017.00394
|
[25]
|
Lu, W., Meng, Z., Hernandez, R. and Zhou, C. (2021) Fibro-blast-Specific IKK-β Deficiency Ameliorates Angiotensin II-Induced Adverse Cardiac Remodeling in Mice. JCI Insight, 6, e150161. https://doi.org/10.1172/jci.insight.150161
|
[26]
|
Wang, X., Zhou, J., Yang, J., Wang, S. and Yang, L. (2020) Role of TLR4/MyD88/NF-κB Signaling in the Contrast-Induced Injury of Renal Tubular Epithelial Cells. Exper-imental and Therapeutic Medicine, 20, 115.
https://doi.org/10.3892/etm.2020.9243
|
[27]
|
Yang, W.X., Wu, Y.H., Wang, M.X., et al. (2022) Effect of Xijiao Dihuang Combined Prescription on Human Dendritic Cell Function Induced by Lipopolysaccharide. Journal of Experi-mental Hematology, 30, 1176-1181.
|
[28]
|
Mudaliar, H., Pollock, C., Komala, M.G., Chadban, S., Wu, H. and Pan-chapakesan, U. (2013) The Role of Toll-Like Receptor Proteins (TLR) 2 and 4 in Mediating Inflammation in Proximal Tubules. American Journal of Physiology-Renal Physiology, 305, F143-F154. https://doi.org/10.1152/ajprenal.00398.2012
|
[29]
|
Kim, S.Y., Shin, S., Kwon, M., et al. (2021) Suppression of the TRIF-Dependent Signaling Pathway of TLRs by Epoxomicin. Archiv der Pharmazie (Weinheim), 354, e2100130. https://doi.org/10.1002/ardp.202100130
|